Drug intelligence / Profile preview

oxotremorine-M

Development stage
Unknown
Modality
Small Molecules
Administration
Implant, Subcutaneous
01

Overview

Oxotremorine-M (oxotremorine methiodide) is a quaternary amine derivative of oxotremorine that acts as a potent, non-selective muscarinic acetylcholine receptor (mAChR) agonist. It is widely utilized as a pharmacological research tool to study cholinergic signaling, synaptic plasticity, and the pathophysiology of neurological disorders such as schizophrenia, Alzheimer's disease, and dystonia. In addition to its primary agonist activity at muscarinic receptors (M1, M2, M3, M4, and M5), oxotremorine-M has been shown to exhibit nicotinic receptor agonist activity and directly potentiate NMDA-mediated ion currents. It is primarily sold as a research-use-only reagent.

Other names
N,N,N-trimethyl-4-(2-oxopyrrolidin-1-yl)but-3-yn-1-aminium iodideoxotremorine Moxotremorine M iodideoxotremorine methiodideoxotremorine-M iodide
02

Targets

M1 (Muscarinic acetylcholine receptor M1)CHRM2 (M2)CHRM3 (M3)CHRM4 (M4)CHRM5 (M5)

Beyond the preview

Go deeper on oxotremorine-M.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxotremorine-M.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call